The new product utilizes oxygen-free technology to stabilize sensitive bacterial strains, ensuring the delivery of clinically relevant organisms. At its core, the supplement pairs a keystone probiotic strain, known for maintaining gut barrier integrity, with heat-treated BPL1®—a postbiotic specifically studied for its impact on abdominal fat reduction and insulin function. According to Dr. David M. Brady, Chief Medical Officer at the company, the development reflects a shift toward addressing the gut–metabolic connection through natural, research-backed pathways rather than synthetic alternatives.

This release follows the company’s recent expansion into advanced microbiome solutions, including the Complete Commensal Probiotic™. While the latter focuses on rebuilding microbial ecosystems through a blend of five commensal strains, the new GLP-1 focused formula is positioned as a targeted tool for those seeking to enhance metabolic markers and digestive comfort. The product is currently available through the company’s professional-grade distribution channels.